PATENT CLAIM ANALYSIS

Application Number: 15951937
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "135100"]

Abstract:
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.

Claim (Index 12):
The method of  claim 1 , wherein the anti-Flt-1 antibody, or an antigen binding fragment thereof, binds to a mouse and/or monkey Flt-1.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 91.0
- Lexical Diversity: 1.42857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14763881', '12069757', '14762373', '14605649', '15637867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6980847562507907
- 35 USC 102 Novelty (BERT): 0.6286807061688847
- Combined Prediction Score: 0.6911443512426001
- Mean Citation Score: 359.35509
- Max Citation Score: 645.3201
- Similarity Product: 496.3825077169776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test